Lori M Gawron, Corinne D Sexsmith, Gentry Carter, Jennifer E Kaiser, Alexandra Woodcock, David K Turok
{"title":"口服紧急避孕开始后继续使用炔诺孕酮避孕植入物一年。","authors":"Lori M Gawron, Corinne D Sexsmith, Gentry Carter, Jennifer E Kaiser, Alexandra Woodcock, David K Turok","doi":"10.1016/j.contraception.2025.110938","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To report the 1-year continuation rate of etonogestrel (ENG) implant users who initiated the method with same-day oral levonorgestrel emergency contraception (EC).</p><p><strong>Study design: </strong>EC clients age 18-35 years at four Utah family planning clinics between February 2021 and April 2023 initiated an ENG implant and completed follow-up surveys through 12-months.</p><p><strong>Results: </strong>At 12 months, we accounted for 132 (82.5%) of 160 participants: 79 (59.8%) still used their implant and 53 (40.2%) discontinued. A higher proportion of privately-insured participants discontinued (42% vs. 24%, p = 0.04).</p><p><strong>Conclusions: </strong>Nearly 60% of participants who chose guideline-supported ENG implant placement at an EC clinical visit continued use at 1 year.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"110938"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"One-year continuation of the etonogestrel contraceptive implant initiated with oral emergency contraception.\",\"authors\":\"Lori M Gawron, Corinne D Sexsmith, Gentry Carter, Jennifer E Kaiser, Alexandra Woodcock, David K Turok\",\"doi\":\"10.1016/j.contraception.2025.110938\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To report the 1-year continuation rate of etonogestrel (ENG) implant users who initiated the method with same-day oral levonorgestrel emergency contraception (EC).</p><p><strong>Study design: </strong>EC clients age 18-35 years at four Utah family planning clinics between February 2021 and April 2023 initiated an ENG implant and completed follow-up surveys through 12-months.</p><p><strong>Results: </strong>At 12 months, we accounted for 132 (82.5%) of 160 participants: 79 (59.8%) still used their implant and 53 (40.2%) discontinued. A higher proportion of privately-insured participants discontinued (42% vs. 24%, p = 0.04).</p><p><strong>Conclusions: </strong>Nearly 60% of participants who chose guideline-supported ENG implant placement at an EC clinical visit continued use at 1 year.</p>\",\"PeriodicalId\":93955,\"journal\":{\"name\":\"Contraception\",\"volume\":\" \",\"pages\":\"110938\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contraception\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.contraception.2025.110938\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.contraception.2025.110938","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
One-year continuation of the etonogestrel contraceptive implant initiated with oral emergency contraception.
Objectives: To report the 1-year continuation rate of etonogestrel (ENG) implant users who initiated the method with same-day oral levonorgestrel emergency contraception (EC).
Study design: EC clients age 18-35 years at four Utah family planning clinics between February 2021 and April 2023 initiated an ENG implant and completed follow-up surveys through 12-months.
Results: At 12 months, we accounted for 132 (82.5%) of 160 participants: 79 (59.8%) still used their implant and 53 (40.2%) discontinued. A higher proportion of privately-insured participants discontinued (42% vs. 24%, p = 0.04).
Conclusions: Nearly 60% of participants who chose guideline-supported ENG implant placement at an EC clinical visit continued use at 1 year.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
